20 Other non-current liabilities
|
|
2021 |
|
2020 |
|---|---|---|---|---|
|
|
|
|
|
Investment grants/ |
|
62 |
|
76 |
Deferred items |
|
24 |
|
24 |
Drawing rights |
|
49 |
|
36 |
Acquisition related liabilities |
|
146 |
|
22 |
Other non-current liabilities |
|
2 |
|
5 |
Total |
|
283 |
|
163 |
The increase in the Other non-current liabilities mainly relates to earn-out agreements regarding the acquisitions of the Amyris F&F bio-based intermediates business and Vestkorn Milling. See also Note 3 Change in the scope of the consolidation.